{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20171101",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "50289",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022460s007s008lbl.pdf",
              "date": "20171103",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20130425",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "38732",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022460s003s004s005lbl.pdf",
              "date": "20130429",
              "type": "Label"
            },
            {
              "id": "29749",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022460Orig1s003,s004,s005ltr.pdf",
              "date": "20130430",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20130425",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "7416",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022460Orig1s003,s004,s005ltr.pdf",
              "date": "20130430",
              "type": "Letter"
            },
            {
              "id": "38731",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022460s003s004s005lbl.pdf",
              "date": "20130429",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20110609",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "7414",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022460s001ltr.pdf",
              "date": "20110613",
              "type": "Letter"
            },
            {
              "id": "17601",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022460s001lbl.pdf",
              "date": "20110610",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20201229",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65774",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022460Orig1s011lbl.pdf",
              "date": "20210106",
              "type": "Label"
            },
            {
              "id": "65813",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022460Orig1s011ltr.pdf",
              "date": "20210104",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20171101",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "50290",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022460s007s008lbl.pdf",
              "date": "20171103",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20130425",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "17603",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022460s003s004s005lbl.pdf",
              "date": "20130429",
              "type": "Label"
            },
            {
              "id": "29748",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022460Orig1s003,s004,s005ltr.pdf",
              "date": "20130430",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20120627",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "7415",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022460s002ltr.pdf",
              "date": "20120629",
              "type": "Letter"
            },
            {
              "id": "17602",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022460s002lbl.pdf",
              "date": "20120628",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20100614",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 4",
          "submission_class_code_description": "Type 4 - New Combination",
          "application_docs": [
            {
              "id": "44757",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022460Orig1s000SumR.pdf",
              "date": "20110203",
              "type": "Summary Review"
            },
            {
              "id": "7413",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022460s000ltr.pdf",
              "date": "20100616",
              "type": "Letter"
            },
            {
              "id": "17600",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022460s000lbl.pdf",
              "date": "20100615",
              "type": "Label"
            },
            {
              "id": "22026",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022460s000_jalyn_toc.html",
              "date": "20110203",
              "type": "Review"
            },
            {
              "id": "23710",
              "url": "http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm258424.htm",
              "date": "20111220",
              "type": "Other Important Information from FDA"
            },
            {
              "id": "29747",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022460s000TAltr.pdf",
              "date": "20100322",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20160613",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        }
      ],
      "application_number": "NDA022460",
      "sponsor_name": "WAYLIS THERAP",
      "openfda": {
        "application_number": [
          "NDA022460"
        ],
        "brand_name": [
          "JALYN"
        ],
        "generic_name": [
          "DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Waylis Therapeutics"
        ],
        "product_ndc": [
          "80725-809"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DUTASTERIDE",
          "TAMSULOSIN HYDROCHLORIDE"
        ],
        "rxcui": [
          "996097",
          "996101"
        ],
        "spl_id": [
          "bc6c62ea-da7b-4c27-a88e-c80cfcd7856d"
        ],
        "spl_set_id": [
          "aab9a2d4-5328-40f3-986f-e7753a928bc0"
        ],
        "package_ndc": [
          "80725-809-13",
          "80725-809-59"
        ],
        "nui": [
          "N0000175836",
          "N0000000126"
        ],
        "pharm_class_epc": [
          "5-alpha Reductase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "5-alpha Reductase Inhibitors [MoA]"
        ],
        "unii": [
          "O0J6XJN02I",
          "11SV1951MR"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "JALYN",
          "active_ingredients": [
            {
              "name": "DUTASTERIDE",
              "strength": "0.5MG"
            },
            {
              "name": "TAMSULOSIN HYDROCHLORIDE",
              "strength": "0.4MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "CAPSULE",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}